Resiniferatoxin Withdrawn Phase 3 Trials for Osteoarthritis of the Knee / Coronavirus Disease 2019 (COVID‑19) / Knee Pain Chronic Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04386980Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Delayed